Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Corona Virus Disease 2019

Journal of Antivirals & Antiretrovirals Pub Date : 2021-01-04 DOI:10.35248/1948-5964.20.S6.002

Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati

引用次数: 2

Abstract

Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.

查看原文本刊更多论文

瑞德西韦和洛匹那韦/利托那韦作为治疗冠状病毒病的潜在药物2019

对SARS-CoV-2有效的药物尚未确定。瑞德西韦和洛匹那韦/利托那韦因其治疗2019冠状病毒病(COVID-19)的潜力而引起了相当大的关注。瑞德西韦不仅在体内，而且在体外测试中都显示出对人类冠状病毒复制的抑制作用，包括SARS-CoV以及洛匹那韦/利托那韦，后者显示出对SARS-CoV-2有希望的抗病毒药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Antivirals & Antiretrovirals

自引率

0.00%

发文量